Polycarbonate Plastics and Neurological Disorders: From Exposure to Preventive Interventions

Plastics are widely used substances that hold a crucial place in today’s economy around the world. Despite their low cost and innumerable applications, they are a serious threat to biological systems and the environment. Therefore, industries are forced to look forward to alternatives that are safe for biological systems and environment friendly. Bisphenol A (BPA) is used to create clear and hard polycarbonate plastic (PCP) containers and bottles. It is also used to make epoxy resins, which are the protective lining inside the metal-based food and beverage cans. BPA can leach out from PCP, epoxy resins and other products that are in contact with foods and drinks, leading to various tissue and organ disorders, especially neurological illnesses. Hence, PCPs can pose greater health hazards when containers having food, water and so on are additionally contaminated by mycotoxins (MTs). Human protection from PCPs is essential, for which environmental and biological monitoring can be helpful. MTs are the secondary metabolites of fungi, which may enter into the food chain in the field, during storage, or at later stages. They are the most substantial and chronic dietary risk elements, which can induce acute to severe disease conditions in human and animals. These toxins are more hazardous than pesticide residues or food additives. Various interventional and preventive measures have to be taken to decrease PCP exposure in human beings. Governments and policymakers should set standards for moderate use of PCPs, and funding for pertinent research is also required.